Back to search

Finland· FI-REL-REL48053

Flucloxacillin Orion

A flucloxacillin product containing flucloxacillin sodium, registered in Finland by Orion Corporation. The same ATC class is registered in 12 of our 19 countries.

ATC J01CF05

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedFlucloxacillin OrionATCJ01CF05REGISTER NO.FI-REL-REL48053PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Flucloxacillin is registered in 12 of 19 countries.

Countries holding a registration under ATC J01CF05 (flucloxacillin), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 6 of them publish a price we can compare per daily dose

Flucloxacillin · ATC J01CF05

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Flucloxacillin sodium
Manufacturer
Orion Corporation
Country
Finland (FI)
ATC code
J01CF05
ATC class
Flucloxacillin
Defined daily dose
3 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Flucloxacillin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All flucloxacillin products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Floxapen, Flucloxacillin Kabi
  • Belgium · Floxapen, Flucloxacilline Fresenius Kabi
  • Czechia · Flucloxacillin Fresenius Kabi, Koryxa
  • Germany · Fluclox, Flucloxacillin Altamedics
  • Denmark · Flucloxacillin Orion, Nerbutix
  • Estonia · Finogi
  • France · Flucloxacilline Arrow
  • United Kingdom (Northern Ireland) · Floxapen, Flucloxacillin
  • Greece · Flucloxacillin Cooper, Skovolen
  • Croatia · Finogi, Flukloksacilin Altamedics
  • Hungary · Flucloxacillin Panpharma
  • Ireland · Floxapen, Flucillin
  • Iceland · Flucloxacillin Wh
  • Italy · Flucacid, Flucloxacillina K24 Pharmaceuticals
  • Luxembourg · Floxapen, Floxapen 1 G Inj
  • Malta · Finogi, Flucloxacillin
  • Netherlands · Flucloxacillin Focus Care Pharmaceuticals, Flucloxacillin Sodium Aurobindo
  • Norway · Nerbutix
  • Portugal · Finogi, Floxapen
  • Sweden · Flucloxacillin Eql Pharma, Flucloxacillin Orion
  • Slovenia · Flukloksacilin Altamedics, Flukloksacilin Kabi
  • Slovakia · Flucloxacillin Fresenius Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7419ea01-22c5-4241-9306-682c640c2a63
GET /v1/drugs/7419ea01-22c5-4241-9306-682c640c2a63?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "2",
  "form": "tabletti, kalvopäällysteinen",
  "route": "Suun kautta",
  "ddd_unit": "g",
  "strength": "1 g",
  "atc_label": "flukloksasilliini",
  "ma_number": "33657",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL48053",
  "authorised_at": "2016-06-27"
}

See everything about flucloxacillin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.